Sign in

CIK 0001478320

  • Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
270907024
Phone
+1 206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Planned sale Chief People Officer sold 79,590 shares at $17.73 ($1,411,131)
  2. 4 Planned sale Chief Financial Officer sold 4,290 shares at $18.00 ($77,220)
  3. 4 Planned sale Chief Scientific Officer sold 10,000 shares at $16.44 ($164,400)
  4. 4/A Planned sale Chief People Officer sold 4,394 shares at $17.50 ($76,895)
  5. 4 Planned sale CEO and Chairman sold 124,998 shares at $15.59 ($1,948,719)
  6. 4 Planned sale Chief People Officer sold 3,125 shares at $16.08 ($50,250)
  7. 4 Planned sale Chief People Officer sold 4,394 shares at $17.50 ($76,895)
  8. 4 Planned sale Chief People Officer sold 113,890 shares at $15.57 ($1,773,267)
  9. 4 Open-market sale Director sold 22,968 shares at $16.00 ($367,488)
  10. 4 Planned sale Chief Commercial Ofc Imm Med sold 12,604 shares at $16.85 ($212,377)
  11. 4 Planned sale Chief Scientific Officer sold 37,212 shares at an average $18.07 ($672,515)
  12. 4 Planned sale Chief Financial Officer sold 162,820 shares at $19.50 ($3,174,990)
  13. 4 Planned sale CEO and Chairman sold 160,734 shares at an average $19.10 ($3,070,747)
  14. 4 Planned sale Chief Commercial Ofc Imm Med sold 606,402 shares at an average $16.73 ($10,144,026)
  15. 4 Open-market sale Chief Financial Officer sold 238 shares at $14.05 ($3,344)
  16. 4 Planned sale Chief Scientific Officer sold 10,000 shares at $14.82 ($148,200)
  17. 4 Planned sale CEO and Chairman sold 89,265 shares at an average $14.73 ($1,315,180)
  18. 4/A Open-market sale Chief Financial Officer sold 1,929 shares at $8.89 ($17,149)
  19. 4 Open-market sale Chief Financial Officer sold 1,929 shares at $8.89 ($17,149)
  20. 4 Planned sale Chief Scientific Officer sold 68,412 shares at $7.35 ($502,828)

Page 5 of 28 · 544 filings